Porcine Membrane vs Bovine Wound Dressing in Human Tooth Extraction Sites

Sponsor
University of Nebraska (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05802602
Collaborator
(none)
24
1
2
14
1.7

Study Details

Study Description

Brief Summary

The purpose of this study is to compare porcine collagen membrane and bovine collagen wound dressing in human tooth extraction sites. The outcomes measured will be soft tissue thickness changes as well as bone density changes.

Condition or Disease Intervention/Treatment Phase
  • Device: Porcine Collagen Membrane
  • Device: Bovine Collagen Dressing
Phase 4

Detailed Description

The purpose of this study is to compare the effectiveness of a porcine collagen membrane to a bovine collagen wound dressing for atraumatic extractions. These are both commonly used as a barrier and containment material over atraumatic extraction sites that are grafted for future implant placement. The study will include nonsmoking adults aged 18-65 requiring premolar or anterior tooth extraction and graft procedures, who are in good general health and willing to provide informed consent. Exclusion criteria include a history of radiation therapy or bisphosphonate use, pregnancy or breastfeeding, systemic conditions that affect bone healing, contraindications to dental implants, and inability to attend follow-up visits. The study will be a double-blind randomized controlled trial involving 24 patients who will be assigned to two groups. Prior to tooth extraction, baseline data will be collected; including gingival crevicular fluid (GCF) sampling, and a limited field Cone Beam Computed Tomography (CBCT) radiograph. A reference digital scan will be taken to measure volumetric changes in soft tissue. Routine, atraumatic extraction of the tooth under local anesthetic will be performed. Following extraction, hydrated AllOss 50/50 DFDBA:FDBA (demineralized freeze-dried bone allograft:freeze-dried bone allograft) bone particulate will be condensed following a routine protocol. One group will receive Mucograft Seal over the graft, and the other group will receive Integra HeliPlug. Patients will be seen at a standard 2-week follow up to remove sutures, have a GCF sampling at the adjacent teeth and take another digital scan. Patients will be seen for an additional 6-week follow up to take a small (2mm) incisional biopsy for histological analysis. Another digital scan and GCF sampling will be taken. Final evaluation will be 3 months post-extraction and will include a localized CBCT evaluation for implant planning and another measure of soft tissue changes with a digital scan. At the time of implant surgery, the core of bone removed during osteotomy will be histologically analyzed for percentage of vital bone. Adverse events will also be recorded at each visit. The primary outcome measure will be the histological composition of tissue at 6 weeks and volumetric tissue changes. The secondary outcome measures will be bone density changes on the post-operative CBCT and inflammatory bio-markers present at baseline, 2-weeks via GCF sampling.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Porcine Collagen Membrane and Bovine Collagen Wound Dressing in Human Extraction Sites With DFDBA Graft: A Randomized Controlled Trial
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Porcine Collagen Membrane

Atraumatic tooth extraction with porcine collagen membrane placement

Device: Porcine Collagen Membrane
Atraumatic tooth extraction with porcine collagen membrane placement
Other Names:
  • Mucograft
  • Active Comparator: Bovine Collagen Dressing

    Atraumatic tooth extraction with bovine collagen dressing placement

    Device: Bovine Collagen Dressing
    Atraumatic tooth extraction with bovine collagen dressing placement
    Other Names:
  • Heliplug
  • Outcome Measures

    Primary Outcome Measures

    1. Soft tissue thickness in mm [6 weeks]

      Soft tissue biopsy to determine tissue thickness, measured in mm

    Secondary Outcome Measures

    1. Bone density in Hounsfield units [Baseline, Three Months]

      CBCT measurement of bone density at baseline and three months, measured in Hounsfield units

    2. Interleukiin - 1beta, measured in pg/mL [Baseline, 6 weeks]

      Interleukin 1beta will be assessed at baseline and 6 weeks via GCF sampling, measured in pg/mL

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • nonsmoking adults

    • aged 18-65

    • requiring premolar or anterior tooth extraction and graft procedures

    • good general health

    • willing to provide informed consent.

    Exclusion Criteria:
    • history of radiation therapy or bisphosphonate use,

    • pregnancy or breastfeeding,

    • systemic conditions that affect bone healing

    • contraindications to dental implants

    • inability to attend follow-up visits.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Nebraska Medical Center College of Dentistry Lincoln Nebraska United States 68503

    Sponsors and Collaborators

    • University of Nebraska

    Investigators

    • Principal Investigator: Amy C Killeen, DDS,MS, UNMC College of Dentistry

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Amy C. Killeen, DDS, MS, Associate Professor, University of Nebraska
    ClinicalTrials.gov Identifier:
    NCT05802602
    Other Study ID Numbers:
    • 0145-23-FB
    First Posted:
    Apr 6, 2023
    Last Update Posted:
    Apr 6, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 6, 2023